- Type / Class
- Equity / Common Stock
- Shares outstanding
- 397,148,913
- Total 13F shares
- 304,073,033
- Share change
- +25,422,355
- Total reported value
- $8,970,179,187
- Put/Call ratio
- 106%
- Price per share
- $29.49
- Number of holders
- 663
- Value change
- +$762,841,036
- Number of buys
- 247
- Number of sells
- 317
Quarterly Holders Quick Answers
What is CUSIP 60770K107?
CUSIP 60770K107 identifies MRNA - Moderna, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 60770K107:
Top shareholders of MRNA - Moderna, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
41,185,295
|
$1,063,816,169 | — | 30 Sep 2025 | |
| BAILLIE GIFFORD & CO |
13D/G
13F
|
Company |
5.3%
|
20,580,514
|
$814,988,354 | -$172,974,542 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.4%
|
29,527,917
|
$762,706,089 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
17,108,595
|
$441,915,009 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
3.1%
|
12,304,297
|
$317,820,001 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
9,962,232
|
$257,324,501 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
9,249,352
|
$238,477,440 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
2.1%
|
8,216,163
|
$212,223,494 | — | 30 Sep 2025 | |
| Theleme Partners LLP |
13F
|
Company |
2%
|
8,068,810
|
$208,417,362 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.9%
|
7,529,981
|
$194,499,409 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.7%
|
6,772,900
|
$174,944,007 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
6,146,374
|
$158,760,840 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
4,801,547
|
$124,023,958 | — | 30 Sep 2025 | |
| Flagship Pioneering, LLC |
13F
|
Company |
1.2%
|
4,632,149
|
$119,648,409 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
4,312,432
|
$111,390,108 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.8%
|
3,179,749
|
$82,132,928 | — | 30 Sep 2025 | |
| BANQUE PICTET & CIE SA |
13F
|
Company |
0.79%
|
3,130,724
|
$80,866,601 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
2,905,509
|
$75,049,297 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.7%
|
2,779,001
|
$71,781,595 | — | 30 Sep 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.68%
|
2,704,838
|
$69,865,933 | — | 30 Sep 2025 | |
| Merck & Co., Inc. |
13F
|
Company |
0.58%
|
2,308,190
|
$59,620,548 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.52%
|
2,082,040
|
$53,779,093 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.51%
|
2,015,828
|
$52,068,838 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.5%
|
1,987,731
|
$51,343,091 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.49%
|
1,960,968
|
$50,651,803 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.49%
|
1,958,694
|
$50,593,066 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.44%
|
1,762,690
|
$45,530,275 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.42%
|
1,657,565
|
$42,814,000 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.41%
|
1,647,071
|
$42,543,844 | — | 30 Sep 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.37%
|
1,449,931
|
$37,451,718 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.35%
|
1,387,041
|
$35,827,285 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.35%
|
1,379,192
|
$35,624,529 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.32%
|
1,262,887
|
$32,620,372 | — | 30 Sep 2025 | |
| Man Group plc |
13F
|
Company |
0.3%
|
1,191,843
|
$30,785,305 | — | 30 Sep 2025 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.3%
|
1,175,765
|
$30,370,009 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.29%
|
1,167,460
|
$30,155,492 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.29%
|
1,162,268
|
$30,021,382 | — | 30 Sep 2025 | |
| Douglas Lane & Associates, LLC |
13F
|
Company |
0.28%
|
1,128,434
|
$29,147,450 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.28%
|
1,102,169
|
$28,469,025 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.28%
|
1,093,499
|
$28,245,079 | — | 30 Sep 2025 | |
| Amundi |
13F
|
Individual |
0.26%
|
1,016,055
|
$27,982,154 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.26%
|
1,032,532
|
$26,670,296 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.25%
|
1,001,259
|
$25,862,522 | — | 30 Sep 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
969,402
|
$25,039,654 | — | 30 Sep 2025 | |
| LETKO, BROSSEAU & ASSOCIATES INC |
13F
|
Company |
0.23%
|
913,390
|
$23,592,864 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.2%
|
801,639
|
$20,696,042 | — | 30 Sep 2025 | |
| Sessa Capital IM, L.P. |
13F
|
Company |
0.19%
|
743,081
|
$19,193,782 | — | 30 Sep 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.19%
|
745,447
|
$18,910,365 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.18%
|
734,489
|
$18,639,023 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.17%
|
674,900
|
$17,432,667 | — | 30 Sep 2025 |
Institutional Holders of Moderna, Inc. - Common Stock (MRNA) as of Q4 2025
As of 31 Dec 2025,
Moderna, Inc. - Common Stock (MRNA) was held by
663 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
304,073,033 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, BAILLIE GIFFORD & CO, STATE STREET CORP, Capital World Investors, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Theleme Partners LLP, and TWO SIGMA ADVISERS, LP.
This page lists
663
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
634
Q4 2025 holders
663
Holder diff
29
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.